The German pharmaceutical-and-agricultural group stated that the deal goals to enhance its ophthalmology pipeline.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Related Posts
Sam Altman house hit with Molotov cocktail, OpenAI office threatened
A display screen shows OpenAI CEO Sam Altman talking throughout the 2026 Infrastructure Summit of presidency officers, company executives, and…
Trump Takes Aim at Chip Makers With New Plan to Throttle Imports
The administration needs home manufacturing to match imports and would impose tariffs on these corporations that don’t step up manufacturing.…
FBI Warning—Major Problem With Apple’s iPhone Encryption
FBI warns on encryption. NurPhoto via Getty Images The encryption on your iPhone is under threat — don’t believe headlines…